Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Vita Life Sciences reports sales growth of $4m as it launches in Vietnam
    • News

    Vita Life Sciences reports sales growth of $4m as it launches in Vietnam

    Pharmaceutical and healthcare company Vita Life Sciences (ASX: VLS) has forecasted a positive growth trajectory for the first half of CY24. Besides expecting sales growth, it is also expecting returns from its recent product launch in Vietnam.  The Company expects sales to rise to between $39 million and $40 million, up from $34.7 million in

    Read More
    Public
  • Titomic secures order from another global defence player for cold spray tech
    • News

    Titomic secures order from another global defence player for cold spray tech

    Increasing their presence in the global defence industry where players are constantly seeking to one-up their rivals, cold spray tech company Titomic (ASX: TTT) has secured another win with new contract orders totalling $476k.  The series of high-value projects come from major international defence primes and suppliers, marking a crucial step forward for Titomic’s innovative

    Read More
    Public
  • XJO expected to open flat, with Tech holding US markets high
    • Market Update

    XJO expected to open flat, with Tech holding US markets high

    The XJO is expected to edge lower on open this morning following a muted night of trading in the U.S which saw their market retake intraday losses to finish marginally higher. Yesterday we tried to retake some of the losses from earlier in the week, but didn’t have the conviction to move away from the

    Read More
    Public
  • Advanced techniques reshaping the power generation market with biomass
    • News

    Advanced techniques reshaping the power generation market with biomass

    Global biomass power generation market is expected to grow due to the advancements in biomass power generation techniques during the forecast period of 2024-2028. According to TechSci Research report,“Biomass Power Generation Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the global biomass power generation market is anticipated to register 4.97% CAGR during the

    Read More
    Public
  • Bubs Australia rebounds in China after CEO fiasco, sees USA growth
    • News

    Bubs Australia rebounds in China after CEO fiasco, sees USA growth

    Baby formula company Bubs Australia (ASX: BUB) has all but closed the chapter on its financial and legal troubles that underlined most of last year.  In the USA, its weekly scan revenue exceeded $1.5 million per week, with over 24,000 tins sold. The number of tins sold increased by 10k to about 24k compared to

    Read More
    Public
  • MMA Offshore increases FY24 earnings guidance amid Cyan takeover bid
    • News

    MMA Offshore increases FY24 earnings guidance amid Cyan takeover bid

    Marine and subsea solutions company MMA Offshore (ASX: MRM) has been up and up, providing positive earnings guidance while negotiating a takeover.  Its earnings visibility and performance across the second half have continued to improve. The Company’s FY24 financials follow a solid FY23, which also saw a stronger-than-expected second half.  MMA Offshore secured several positive

    Read More
    Public
  • «
  • ‹
  • 67
  • 68
  • 69
  • 70
  • 71
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.